share_log

HC Wainwright & Co. Reiterates Buy on Cullinan Oncology, Lowers Price Target to $34

Benzinga ·  Aug 11, 2023 13:10

HC Wainwright & Co. analyst Edward White reiterates Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $49 to $34.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment